Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wrist-Worn blood pressure monitor put to the test against gold standard

NCT ID NCT07713576

Diagnosis Sponsor: Huawei Device Co., Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial checks whether a wrist-worn blood pressure monitor (Model: RIV-B10) can measure blood pressure as accurately as the traditional arm cuff and mercury device. About 158 adults aged 18 and older with wrist sizes between 13 and 21 cm will have their blood pressure taken with both devices at rest, during daily activities, and after exercise. The goal is to see if the wrist monitor meets international accuracy standards for safe home use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wrist ambulatory blood pressure monitor (Model: RIV-B10) compared to mercury sphygmomanometer
What this could lead to
If accurate, this wrist monitor could offer a convenient, portable way to track blood pressure throughout daily life.
What could go wrong
This is a device accuracy study, not a treatment trial. The monitor may not meet strict accuracy standards, especially during movement or exercise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

158 people

The number who actually took part.

Started

Apr 2026

Finished

Jun 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

People over 18 years old

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Voluntarily participate in this clinical trial and sign informed consent; 2. Subjects must be willing and able to comply with the study steps; 3. Subjects aged 18 and above with wrist circumferences of 13.0-21.0 cm. Exclusion Criteria: 1. Subjects whose ECG during the screening period showed severe arrhythmias (atrial fibrillation, atrial flutter, ventricular flutter, ventricular fibrillation, ventricular tachycardia, junctional tachycardia, sinus arrest, pathological sinoatrial node syndrome, pacemaker rhythm); 2. Subjects with sickle cell disease; 3. Subjects who have undergone previous mastectomy or arm lymph node resection; 4. Subjects allergic to nylon, fluor rubber, or hydrogenated nitrile rubber (HNBR); 5. Subjects with wounds on the limbs at the measurement site or inflammation in the wrist; 6. Subjects undergoing intravenous infusion, blood transfusion, or other catheter insertion at the measurement site of the limb; 7. Those who ate, drank alcohol, smoked, or exercised vigorously within 30 minutes prior to the study; 8. Subjects who have participated in other clinical investigations that may affect this trial within the past 30 days; 9. Investigator believe that subjects should not participate in this clinical trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood pressure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood pressure

Contacts and locations

Locations

  • Chenzhou First People's Hospital

    Chenzhou, Hunan, 423000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.